Zevia PBC ZVIA
Zevia PBC ("Zevia PBC") was incorporated as a Delaware public benefit corporation on March 23, 2021, and prior to the consummation of the reorganization and initial public offering ("IPO"), did not conduct any activities other than those incidental to our formation and the IPO. In connection with the completion of the IPO on July 26, 2021, Zevia PBC became a holding company, and its sole material asset is a controlling equity interest in Zevia LLC, a Delaware limited liability company ("Zevia LLC"). As the sole managing member of Zevia LLC, Zevia PBC operates and controls all of the business and affairs of Zevia LLC and, through Zevia LLC, conducts its business. Subsequent to July 26, 2021, Zevia PBC consolidates the results of Zevia LLC with a non-controlling interest reflected for the portion of Zevia LLC not owned by Zevia PBC. For more information about our holding company reorganization, see the section titled "Organizational Structure—The Reorganization" in the prospectus dated July 21, 2021, and filed with the U.S. Securities and Exchange Commission ("SEC") on July 23, 2021.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- United States
- Canada
| Region | FY2025 | FY2024 |
|---|---|---|
| United States | $144.9M | $139.7M |
| Canada | $16.3M | $15.3M |
As the company reported it, from the “Note 3 - Revenues - Disaggregation of Revenue (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $161.3M | $155.0M | $166.4M | $163.2M | $138.2M | $110.0M | — |
| Cost of revenue | $83.8M | $83.1M | $91.7M | $93.2M | $74.2M | $60.5M | — |
| Gross profit | $77.4M | $71.9M | $74.8M | $70.0M | $63.9M | $49.5M | — |
| SG&A | $30.0M | $30.0M | $31.5M | $36.8M | $27.5M | $18.8M | — |
| Total operating expenses | $89.2M | $95.6M | $103.7M | $117.9M | $151.4M | $55.0M | — |
| Operating income | -$11.8M | -$23.7M | -$28.9M | -$47.9M | -$87.4M | -$5.5M | — |
| Pre-tax income | -$11.1M | -$23.7M | -$28.3M | -$47.6M | -$87.6M | -$6.1M | — |
| Income tax | $54.0K | $66.0K | $52.0K | $65.0K | $34.0K | $0 | — |
| Net income | -$9.9M | -$20.0M | -$28.3M | -$47.6M | -$87.7M | -$6.1M | — |
| EPS, basic | -0.15 | -0.34 | -0.41 | -0.81 | -1.33 | — | — |
| EPS, diluted | -0.15 | -0.34 | -0.41 | -0.81 | -1.33 | — | — |
| Shares, diluted (wtd. avg.) | 66.0M | 58.7M | 50.6M | 43.5M | 34.5M | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $25.4M | $30.7M | $32.0M | $47.4M | $43.1M | $14.9M | $3.2M |
| Short-term investments | — | — | — | $0 | $30.0M | $0 | — |
| Receivables | $11.1M | $10.8M | $11.1M | $11.1M | $9.0M | $6.9M | — |
| Inventory | $20.4M | $18.6M | $34.5M | $27.6M | $31.5M | $20.8M | — |
| Total current assets | $58.2M | $61.9M | $82.7M | $88.7M | $117.1M | $44.2M | — |
| Property, plant and equipment | $867.0K | $1.3M | $2.1M | $4.6M | $3.2M | $991.0K | — |
| Other intangibles | $3.1M | $3.2M | $3.5M | $4.4M | $4.2M | $3.9M | — |
| Total assets | $63.6M | $68.0M | $90.9M | $98.9M | $125.0M | $50.0M | — |
| Accounts payable | $17.6M | $15.3M | $21.2M | $8.0M | $13.5M | $9.0M | — |
| Total current liabilities | $28.0M | $24.2M | $27.7M | $17.1M | $20.4M | $14.1M | — |
| Total liabilities | $28.0M | $25.0M | $29.1M | $17.1M | $20.4M | $14.3M | — |
| Retained earnings | -$131.3M | -$121.3M | -$101.3M | -$79.8M | -$46.0M | $0 | — |
| Total equity | $51.0M | $64.9M | $61.8M | $81.8M | $104.6M | -$196.8M | -$40.0M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.7M | -$1.0M | -$16.3M | -$20.8M | -$17.8M | -$3.3M | — |
| Depreciation and amortisation | $868.0K | $1.3M | $1.6M | $1.3M | $997.0K | $932.0K | — |
| Stock-based compensation | $3.8M | $5.0M | $8.3M | $26.9M | $77.7M | $7.9M | — |
| Capital expenditure | $307.0K | $283.0K | — | $2.6M | $3.1M | $805.0K | — |
| Investing cash flow | -$307.0K | -$283.0K | $805.0K | $27.4M | -$33.1M | -$805.0K | — |
| Financing cash flow | -$289.0K | $0 | $25.0K | -$2.3M | $79.1M | $15.8M | — |
| Buybacks | — | — | — | $0 | $17.0K | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001437749-26-005601.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $110.0M | $138.2M | $163.2M | $166.4M | $155.0M | $161.3M |
| Gross profit | — | $49.5M | $63.9M | $70.0M | $74.8M | $71.9M | $77.4M |
| Net income | — | -$6.1M | -$87.7M | -$47.6M | -$28.3M | -$20.0M | -$9.9M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
- Results announced Item 2.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Officer or director change Item 5.02
- Regulation FD disclosure Item 7.01
- Results announced Item 2.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 2086
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MNST | Monster Beverage Corp | $45.24B | — | 10.7% |
| CELH | Celsius Holdings, Inc. | $7.20B | 113.9x | 85.5% |
| FIZZ | NATIONAL BEVERAGE CORP | $3.38B | 18.4x | -1.7% |
| REED | REED'S, INC. | $7.0M | — | -10.2% |
| CCEP | COCA-COLA EUROPACIFIC PARTNERS plc | — | — | — |
| COKE | Coca-Cola Consolidated, Inc. | — | — | 4.8% |
| FMX | MEXICAN ECONOMIC DEVELOPMENT INC | — | — | — |
| KOF | COCA COLA FEMSA SAB DE CV | — | — | -10.5% |